Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dyax Corp (DYAX)

Dyax Corp (DYAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dyax Corp 55 NETWORK DRIVE BURLINGTON MA 01803-2756

www.dyax.com P: 617-225-2500

Description:

Dyax Corp is a biopharmaceutical company that has developed and patented a method that is used to identify a broad range of compounds with potential for the treatment and diagnosis of diseases. The company is also using this method to identify compounds that could be used in purifying andmanufacturing biopharmaceuticals and other chemicals. The company's phage display technology to rapidly and cost-effectively determine the potential medical uses of newly discovered proteins and genes and subsequently discover biopharmaceutical product candidates.

Key Statistics

Overview:

Market Capitalization, $K 5,638,660
Shares Outstanding, K 146,360
Annual Sales, $ 81,720 K
Annual Net Income, $ -11,880 K
Last Quarter Sales, $ 24,730 K
Last Quarter Net Income, $ -11,700 K
60-Month Beta 1.41
% of Insider Shareholders 5.97%
% of Institutional Shareholders 95.95%

Growth:

1-Year Return 143.69%
3-Year Return 1,159.34%
5-Year Return 1,910.99%
5-Year Revenue Growth 277.63%
5-Year Earnings Growth -89.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 10/28/15
Next Earnings Date 02/23/16
Earnings Per Share ttm -0.21
EPS Growth vs. Prev Qtr -33.33%
EPS Growth vs. Prev Year -700.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DYAX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -14.14%
Return-on-Assets % -9.85%
Profit Margin % -14.54%
Debt/Equity 0.00
Price/Sales 41.10
Price/Cash Flow N/A
Price/Book 17.88
Book Value/Share 2.15
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar